Acute megakaryoblastic leukemia in down syndrome: genes and variants
Explore variant evidence for Acute megakaryoblastic leukemia in down syndrome across 4 analyzed proteins (JAK1, NRAS, SRSF2, GATA1). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Acute megakaryoblastic leukemia in down syndrome
JAK1: Tyrosine-protein kinase JAK1
It couples many cytokine receptors to STAT transcription factors and is essential for interferon, interleukin, and growth-factor signaling. Loss-of-function can cause immunodeficiency, whereas activating alterations contribute to inflammatory disease and some malignancies.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in JAK1 have source records linked to Acute megakaryoblastic leukemia in down syndrome. Association strength is not clinical gene validity.
NRAS: GTPase NRas
Its active GTP-bound state drives RAF-MEK-ERK and PI3K signaling downstream of growth-factor receptors. Somatic activating variants are common drivers of melanoma, leukemia, and other cancers, while germline activating variants can cause Noonan syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NRAS have source records linked to Acute megakaryoblastic leukemia in down syndrome. Association strength is not clinical gene validity.
SRSF2: Serine/arginine-rich splicing factor 2
It helps select splice sites during pre-mRNA processing and coordinates multiple stages of RNA maturation. Recurrent P95 hotspot mutations change RNA-binding preferences and are common in myelodysplastic syndromes, chronic myelomonocytic leukemia, and AML.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SRSF2 have source records linked to Acute megakaryoblastic leukemia in down syndrome. Association strength is not clinical gene validity.
GATA1: Erythroid transcription factor
It directs erythroid and megakaryocytic differentiation by activating lineage-specific genes and suppressing alternative hematopoietic programs. Germline variants can cause anemia and thrombocytopenia syndromes, while acquired N-terminal mutations are characteristic of transient abnormal myelopoiesis and myeloid leukemia in Down syndrome.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GATA1 have source records linked to Acute megakaryoblastic leukemia in down syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Acute megakaryoblastic leukemia in down syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NRAS G13D | 13 | Pathogenic / likely pathogenic (★★) | |
| JAK1 L783F | 783 | Protein kinase 1 | Pathogenic / likely pathogenic (★) |
| SRSF2 P95R | 95 | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Noonan syndrome also has ClinVar records linked to NRAS variants; they fall mostly in different places as the Acute megakaryoblastic leukemia in down syndrome variants (9 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to NRAS variants; they fall mostly in different places as the Acute megakaryoblastic leukemia in down syndrome variants (6 pathogenic / likely pathogenic).
Diseases related to Acute megakaryoblastic leukemia in down syndrome
- Acute myeloid leukemia, also linked to NRAS and SRSF2
- Hypertrophic cardiomyopathy, also linked to NRAS
- RASopathy, also linked to NRAS
- Noonan syndrome, also linked to NRAS
- Noonan syndrome and Noonan-related syndrome, also linked to NRAS
- Cardiofaciocutaneous syndrome, also linked to NRAS
- Autoimmune lymphoproliferative syndrome, also linked to NRAS
- Colorectal cancer, also linked to NRAS
- Costello syndrome, also linked to NRAS
- Vascular malformation, also linked to NRAS
- Multiple myeloma, also linked to NRAS
- Crohn disease, also linked to JAK1
Frequently asked questions
Which genes have records linked to Acute megakaryoblastic leukemia in down syndrome?
This view contains 4 analyzed proteins: JAK1, NRAS, SRSF2, GATA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 5 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center